HK1252391A1 - 用於預防和治療hsv-2感染的dna疫苗 - Google Patents

用於預防和治療hsv-2感染的dna疫苗

Info

Publication number
HK1252391A1
HK1252391A1 HK18111688.4A HK18111688A HK1252391A1 HK 1252391 A1 HK1252391 A1 HK 1252391A1 HK 18111688 A HK18111688 A HK 18111688A HK 1252391 A1 HK1252391 A1 HK 1252391A1
Authority
HK
Hong Kong
Prior art keywords
infection
preventing
dna vaccine
treating hsv
hsv
Prior art date
Application number
HK18111688.4A
Other languages
English (en)
Inventor
Yong-Bok Seo
Ju-A Shin
Original Assignee
Sl Vaxigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sl Vaxigen Inc filed Critical Sl Vaxigen Inc
Publication of HK1252391A1 publication Critical patent/HK1252391A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18111688.4A 2016-09-28 2018-09-12 用於預防和治療hsv-2感染的dna疫苗 HK1252391A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160125149A KR101962683B1 (ko) 2016-09-28 2016-09-28 Hsv-2 감염 예방 및 치료용 dna 백신

Publications (1)

Publication Number Publication Date
HK1252391A1 true HK1252391A1 (zh) 2019-05-24

Family

ID=60912229

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18111688.4A HK1252391A1 (zh) 2016-09-28 2018-09-12 用於預防和治療hsv-2感染的dna疫苗

Country Status (5)

Country Link
KR (1) KR101962683B1 (zh)
CN (1) CN108419437B (zh)
HK (1) HK1252391A1 (zh)
TW (1) TWI697558B (zh)
WO (1) WO2018009047A2 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116497049B (zh) * 2023-05-04 2024-03-22 江苏三仪生物工程有限公司 一种表达犬疱疹病毒gD糖基化蛋白的重组菌及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541011B2 (en) * 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
US7196066B1 (en) * 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US6821519B2 (en) * 2000-06-29 2004-11-23 Corixa Corporation Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
CN1301749C (zh) * 2005-12-09 2007-02-28 复旦大学 抗单纯疱疹病毒－2感染的多表位dna疫苗及其制备方法
US8802109B2 (en) * 2007-07-05 2014-08-12 University Of Kansas Herpes simplex virus mutant ICP0
JP5771605B2 (ja) * 2009-05-22 2015-09-02 ジェノセア バイオサイエンシーズ， インコーポレイテッド 単純ヘルペスウイルス２型に対するワクチン：免疫応答を誘発する組成物および方法
US20130224236A1 (en) * 2010-11-03 2013-08-29 University Of Washington Hsv-1 epitopes and methods for using same
EA034351B1 (ru) * 2012-05-16 2020-01-30 Иммьюн Дизайн Корп. Трехкомпонентная вакцина против впг-2 и способы ее применения

Also Published As

Publication number Publication date
TW201814043A (zh) 2018-04-16
KR101962683B1 (ko) 2019-03-27
KR20180035092A (ko) 2018-04-05
CN108419437B (zh) 2020-09-29
TWI697558B (zh) 2020-07-01
CN108419437A (zh) 2018-08-17
WO2018009047A2 (en) 2018-01-11
WO2018009047A3 (en) 2018-02-15

Similar Documents

Publication Publication Date Title
IL263558A (en) papd5 and papd7 inhibitors for the treatment of hepatitis b infection
IL248951B (en) Inductive heating device and system for creating a spray
GB2545761B (en) Handling move instructions using register renaming
IL312809A (en) Methods for treating hepatitis B infection
IL253594B (en) The manipulation detection vehicle for a robotic surgical system
IL256972A (en) Methods for detecting and treating low-virulence infections
IL247938A0 (en) Onconas for use in the treatment or prevention of viral infections
PL3135623T3 (pl) Urządzenie chwytająco-podnoszące
GB201500665D0 (en) Patient handling system and method
GB201621732D0 (en) A multi-epitope dna vaccine for heartwater
GB201402909D0 (en) Treating infection
IL250175B (en) A peptide derived from koc1 and a component containing it
HK1252391A1 (zh) 用於預防和治療hsv-2感染的dna疫苗
IL253878A0 (en) An effective substance for the treatment of respiratory inflammation
EP3197465A4 (en) Compositions and methods for treating a viral infection
GB201815084D0 (en) A treatment system
IL252393A0 (en) Systems and methods for differential detection of viral infection
GB201621384D0 (en) Gene signatures for cancer detection and treatment
AP2016009014A0 (en) Method for treating hiv infection
GB2539824B (en) Gripping device, and pipe handling system comprising at least one gripping device
GB201609944D0 (en) Gene signatures for cancer detection and treatment
GB201604398D0 (en) Gene signatures for cancer detection and treatment
EP3223816A4 (en) Methods for treating a cytomegalovirus infection
GB201410889D0 (en) A fungal infection treatment
AU2014900488A0 (en) Agents and methods for inhibiting virus infection